CNTA
Centessa Pharmaceuticals plc
$23.38
+$0.59(+2.59%)
66
Overall
--
Value
66
Tech
--
Quality
Market Cap
$2.86B
Volume
566.19K
52W Range
$9.60 - $23.51
Target Price
$33.00
Order:
Income Statement
| Metric | Trend | Chart | 2022 Dec | 2023 Dec |
|---|---|---|---|---|
| REVENUE | ||||
| Total Revenue | -- | $6.9M | ||
| Total Revenue | -- | $6.9M | ||
| GROSS PROFIT | ||||
| Gross Profit | -- | $6.9M | ||
| OPERATING EXPENSES | ||||
| Operating Expenses | $210.3M | $178.1M | ||
| Research & Development | $155.1M | $124.4M | ||
| Research Expense | $155.1M | $124.4M | ||
| Selling, General & Administrative | $55.2M | $53.7M | ||
| General & Administrative Expenses | $55.2M | $53.7M | ||
| Depreciation & Amortization | $131.0K | $298.0K | ||
| Depreciation & Amortization | $131.0K | $298.0K | ||
| Amortization | -- | $500.0K | ||
| Other Operating Expenses | -- | $-2.6M | ||
| OPERATING INCOME | ||||
| Operating income | $-212.3M | $-171.3M | ||
| EBITDA | $-209.5M | $-165.4M | ||
| NON-OPERATING ITEMS | ||||
| Interest Expense (Non-Operating) | $7.3M | $9.9M | ||
| Intinc | $244.0K | $10.5M | ||
| Net Non-Operating Interest Income/Expense | $-7.0M | $570.0K | ||
| Other Income/Expense | $362.0K | $5.4M | ||
| Other Special Charges | $2.3M | $-5.4M | ||
| PRE-TAX INCOME | ||||
| EBIT | $-209.7M | $-166.2M | ||
| Pre-Tax Income | $-217.0M | $-176.1M | ||
| INCOME TAX | ||||
| Tax Provision | $-747.0K | $-25.1M | ||
| NET INCOME | ||||
| Net Income | $-216.2M | $-151.1M | ||
| Net Income (Continuing Operations) | $-216.2M | $-151.1M | ||
| Net Income (Discontinued Operations) | $-216.2M | $-151.1M | ||
| Net Income (Common Stockholders) | $-214.2M | $-151.1M | ||
| TOTALS | ||||
| Total Expenses | $210.3M | $178.1M | ||
| SHARE & EPS DATA | ||||
| Average Shares Outstanding | $93.4M | $96.2M | ||
| Average Shares Outstanding (Diluted) | $93.4M | $96.2M | ||
| Shares Outstanding | $95.0M | $100.3M | ||
| Basic EPS | $-2.31 | $-1.57 | ||
| Basic EPS (Continuing Operations) | $-2.31 | $-1.57 | ||
| Diluted EPS | $-2.31 | $-1.57 | ||
| Diluted EPS (Continuing Operations) | $-2.31 | $-1.57 | ||
| OTHER METRICS | ||||
| Other Gand A | $55.2M | $53.7M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CNTA | $23.38 | +2.6% | 566.19K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Centessa Pharmaceuticals plc Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW